SIECZKAREK MARK M
Insider CIK 1188738 · SLTM Interim Chairman/President/CEO, Director · WIZP Director · NBY CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| WIZP Wize Pharma, Inc. | A Award deriv | 2020-08-11 | 2020-08-13 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award | 2019-07-30 | 2019-08-06 | 167,938 | — | $0 | 1,156,883 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2019-05-30 | 2019-10-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2017-06-02 | 2017-06-06 | 250,000 | — | $0 | 250,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2017-01-25 | 2017-01-26 | 238,609 | — | $0 | 936,857 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | X Exercise | 2016-09-30 | 2016-10-03 | 273,447 | $1.91 | $522.3K | 988,945 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2016-08-01 | 2016-08-02 | 130,890 | — | $0 | 273,447 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award | 2016-08-01 | 2016-08-02 | 261,780 | $1.91 | $500.0K | 715,498 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2016-06-06 | 2016-06-08 | 675,000 | — | $0 | 698,248 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2016-05-09 | 2016-05-13 | 130,890 | — | $0 | 142,557 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award | 2016-05-09 | 2016-05-13 | 261,780 | $1.91 | $500.0K | 453,718 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2016-03-09 | 2016-03-09 | 58,692 | — | $0 | 58,692 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award | 2016-02-25 | 2016-02-26 | 125,387 | $1.91 | $239.5K | 133,246 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2016-01-04 | 2016-01-06 | 16,032 | — | $0 | 23,246 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2015-06-12 | 2015-06-16 | 24,128 | — | $0 | 180,362 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy deriv | 2015-03-03 | 2015-03-05 | 124,999 | $0.65 | $81.2K | 291,665 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy deriv | 2015-03-03 | 2015-03-05 | 166,666 | $0.60 | $100.0K | 291,665 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy | 2015-03-03 | 2015-03-05 | 166,666 | $0.60 | $100.0K | 196,466 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2015-01-02 | 2015-01-06 | 92,667 | — | $0 | 156,234 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy | 2014-06-04 | 2014-06-05 | 4,800 | $0.89 | $4.3K | 29,800 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy | 2014-05-19 | 2014-05-21 | 25,000 | $0.88 | $22.0K | 25,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2014-01-30 | 2014-01-31 | 33,567 | — | $0 | 63,567 | SEC↗ |
| SLTM SOLTA MEDICAL INC | D To issuer deriv | 2014-01-23 | 2014-01-27 | 25,000 | $1.53 | $38.3K | 0 | SEC↗ |
| SLTM SOLTA MEDICAL INC | D To issuer deriv | 2014-01-23 | 2014-01-27 | 25,000 | $0.45 | $11.3K | 0 | SEC↗ |
| SLTM SOLTA MEDICAL INC | U Tender | 2014-01-23 | 2014-01-27 | 269,514 | $2.92 | $787.0K | 0 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2014-01-09 | 2014-01-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SLTM SOLTA MEDICAL INC | A Award | 2013-12-31 | 2014-01-02 | 7,710 | — | $0 | 268,598 | SEC↗ |
| SLTM SOLTA MEDICAL INC | A Award | 2013-11-30 | 2013-12-03 | 10,095 | — | $0 | 260,888 | SEC↗ |
| SLTM SOLTA MEDICAL INC | A Award | 2013-10-31 | 2013-11-04 | 9,461 | — | $0 | 250,793 | SEC↗ |
| SLTM SOLTA MEDICAL INC | A Award | 2013-09-30 | 2013-11-04 | 9,151 | — | $0 | 241,332 | SEC↗ |
| SLTM SOLTA MEDICAL INC | A Award | 2013-08-30 | 2013-11-04 | 7,579 | — | $0 | 232,181 | SEC↗ |
| SLTM SOLTA MEDICAL INC | A Award | 2013-06-05 | 2013-06-07 | 31,627 | — | $0 | 224,602 | SEC↗ |
| SLTM SOLTA MEDICAL INC | P Buy | 2013-05-06 | 2013-05-07 | 150,000 | $1.74 | $261.0K | 192,975 | SEC↗ |
| SLTM SOLTA MEDICAL INC | A Award | 2012-06-07 | 2012-06-11 | 22,909 | — | $0 | 42,975 | SEC↗ |